A survey of opinions and beliefs concerning surgery for malignant pleural mesothelioma amongst 802 members of the european association for cardio-thoracic surgery (EACTS), the European society of thoracic surgeons (ESTS) and the society of thoracic surgeons (STS)

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 3, 2011, Pages 341-346

  Treasure, Tom ^a   Internullo, Eveline ^b   Fiorentino, Francesca ^a   van Raemdonck, Dirk ^c   van Schil, Paul ^d   DeCamp, Malcolm ^e   Wood, Douglas ^f   Utley, Martin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Extrapleural pneumonectomy; Mesothelioma; Pleurectomy; Survey

Indexed keywords

CANCER ADJUVANT THERAPY; CLINICAL PRACTICE; CYTOREDUCTIVE SURGERY; EDITORIAL; HEALTH BELIEF; HEALTH PERSONNEL ATTITUDE; HUMAN; LUNG RESECTION; MEDICAL SOCIETY; PERCEPTION; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; QUESTIONNAIRE; SURGEON; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ATTITUDE OF HEALTH PERSONNEL; EUROPE; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MESOTHELIOMA; PATIENT SELECTION; PLEURAL NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK ASSESSMENT; SOCIETIES, MEDICAL; THORACIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 79952354432     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.251488     Document Type: Editorial

References (7)

1. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-672.
2. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005;92:587-593.
3. Hasani A, Alvarez JM, Wyatt JM, Bydder S, Millward M, Byrne M, Musk A, Nowak A. Outcome for patients with malignant pleural mesothelioma referred for trimodality therapy in Western Australia. J Thorac Oncol 2009;4:1010-1016.
4. Tsao AS, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothelio-ma. J Clin Oncol 2009;27:2081-2090.
5. Treasure T. Surgery for mesothelioma: MARS landing and future missions. Eur J Cardiothorac Surg 2010;37:509-510.
6. Van Schil PE, Baas P, Gaafar R, Maat AP, van de Pol M, Hasan B, Klomp HM, Abdelrahman AM, Welch J, van Meerbeeck J; European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 2010;36:1362-1369.
7. Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le Pchoux C, Mutt L, Pairon J-C, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malig nant pleural mesothelioma. Eur Respir J 2010;35:479-495.